skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialooctaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-[alpha-l-fucosyl-(1->4)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-[alpha-l-fucosyl-(1->3)]-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

مفهوم‌های اخص

بار

  • -1

فرمول

  • C67H109N4O49R2

والد-عملکردی دارد

بخشی دارد

جرم

  • 1754.583

جرم تک‌ایزوتوپی

  • 1753.61604

اسمایلٓ

  • O([C@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)C)O)O)O)[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@H]([C@@H]([C@@H]([C@@H](O5)C)O)O)O)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O[C@]7(O[C@@]([C@@H]([C@H](C7)O)NC(C)=O)([H])[C@@H]([C@@H](CO)O)O)C(=O)[O-])O)NC(C)=O)O)CO)O[C@@H]8[C@H]([C@@H](O[C@@H]([C@@H]8O)CO)O[C@H]9[C@@H]([C@H]([C@@H](O[C@@H]9CO)OC[C@@H]([C@@H](*)O)NC(=O)*)O)O)O)NC(C)=O

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(1-)
  • a neolactoside IV(3)-beta-[NeuAc-alpha-(2->3)-Gal-beta-(1->3)-[Fuc-alpha-(1->4)]-GlcNAc],III(3)-alpha-Fuc-nLc4Cer

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:145004

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD